BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
1445746	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H23ClN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-9-26-23(19)29)27-20(21)14-5-8-25-11-18(14)32-12-13-7-10-31-13/h2-5,8,11,13,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	AOAHZOQPEJYOCJ-UHFFFAOYSA-N	696414	3-(3-chlor-2-methoxyanilino)-2-[3-(oxetan-2-ylmethoxy)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-on::US20240307362, Example 1	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.152							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; SÜLZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696414	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696414&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445747	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@@H]1CCO1 |r|	InChI=1S/C23H23ClN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-9-26-23(19)29)27-20(21)14-5-8-25-11-18(14)32-12-13-7-10-31-13/h2-5,8,11,13,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	AOAHZOQPEJYOCJ-UHFFFAOYSA-N	696415	3-(3-chlor-2-methoxyanilino)-2-{3-[(2S)-oxetan-2-ylmethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-on::US20240307362, Example 2	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.144							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; SÜLZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696415	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696415&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445748	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@H]1CCO1 |r|	InChI=1S/C23H23ClN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-9-26-23(19)29)27-20(21)14-5-8-25-11-18(14)32-12-13-7-10-31-13/h2-5,8,11,13,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	AOAHZOQPEJYOCJ-UHFFFAOYSA-N	696421	3-(3-chloro-2-methoxyanilino)-2-(3-{[(2R)-oxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 3	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		<0.073							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696421	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696421&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445749	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H23FN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-9-26-23(19)29)27-20(21)14-5-8-25-11-18(14)32-12-13-7-10-31-13/h2-5,8,11,13,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	KNPAUZQLPGIQGC-UHFFFAOYSA-N	696422	3-(3-fluoro-2-methoxyanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 4	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.356							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696422	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696422&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445750	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@@H]1CCO1 |r|	InChI=1S/C23H23FN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-9-26-23(19)29)27-20(21)14-5-8-25-11-18(14)32-12-13-7-10-31-13/h2-5,8,11,13,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	KNPAUZQLPGIQGC-UHFFFAOYSA-N	696423	3-(3-fluoro-2-methoxyanilino)-2-(3-{[(2S)-oxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 5	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.074							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696423	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696423&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445751	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@H]1CCO1 |r|	InChI=1S/C23H23FN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-9-26-23(19)29)27-20(21)14-5-8-25-11-18(14)32-12-13-7-10-31-13/h2-5,8,11,13,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	KNPAUZQLPGIQGC-UHFFFAOYSA-N	696424	3-(3-fluoro-2-methoxyanilino)-2-(3-{[(2R)-oxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 6	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.522							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696424	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696424&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445752	Cc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H23ClN4O3/c1-13-16(24)3-2-4-17(13)27-22-20-18(6-9-26-23(20)29)28-21(22)15-5-8-25-11-19(15)31-12-14-7-10-30-14/h2-5,8,11,14,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	WULQFTQXGPGDQW-UHFFFAOYSA-N	696425	3-(3-chloro-2-methylanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 7	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.184							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696425	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696425&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445753	Cc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@@H]1CCO1 |r|	InChI=1S/C23H23ClN4O3/c1-13-16(24)3-2-4-17(13)27-22-20-18(6-9-26-23(20)29)28-21(22)15-5-8-25-11-19(15)31-12-14-7-10-30-14/h2-5,8,11,14,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	WULQFTQXGPGDQW-UHFFFAOYSA-N	696426	3-(3-chloro-2-methylanilino)-2-(3-{[(2S)-oxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 8	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.142							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696426	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696426&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445754	Cc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@H]1CCO1 |r|	InChI=1S/C23H23ClN4O3/c1-13-16(24)3-2-4-17(13)27-22-20-18(6-9-26-23(20)29)28-21(22)15-5-8-25-11-19(15)31-12-14-7-10-30-14/h2-5,8,11,14,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	WULQFTQXGPGDQW-UHFFFAOYSA-N	696427	3-(3-chloro-2-methylanilino)-2-(3-{[(2R)-oxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 9	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.442							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696427	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696427&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445755	Clc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2CCO2)c1Cl	InChI=1S/C22H20Cl2N4O3/c23-14-2-1-3-16(19(14)24)28-21-18-15(5-8-26-22(18)29)27-20(21)13-4-7-25-10-17(13)31-11-12-6-9-30-12/h1-4,7,10,12,27-28H,5-6,8-9,11H2,(H,26,29)	FIHUXIWCQZUVOU-UHFFFAOYSA-N	696428	3-(2,3-dichloroanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 10	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.133							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696428	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696428&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445756	Clc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2CCO2)c1Cl	InChI=1S/C22H20Cl2N4O3/c23-14-2-1-3-16(19(14)24)28-21-18-15(5-8-26-22(18)29)27-20(21)13-4-7-25-10-17(13)31-11-12-6-9-30-12/h1-4,7,10,12,27-28H,5-6,8-9,11H2,(H,26,29)	FIHUXIWCQZUVOU-UHFFFAOYSA-N	696429	(+)-3-(2,3-dichloroanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 11	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.157							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696429	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696429&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445757	Clc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2CCO2)c1Cl	InChI=1S/C22H20Cl2N4O3/c23-14-2-1-3-16(19(14)24)28-21-18-15(5-8-26-22(18)29)27-20(21)13-4-7-25-10-17(13)31-11-12-6-9-30-12/h1-4,7,10,12,27-28H,5-6,8-9,11H2,(H,26,29)	FIHUXIWCQZUVOU-UHFFFAOYSA-N	696430	(&#8722;)-3-(2,3-dichloroanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 12	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.233							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696430	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696430&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445758	COc1c(Cl)c(F)ccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H22ClFN4O4/c1-31-22-16(3-2-14(25)19(22)24)29-21-18-15(5-8-27-23(18)30)28-20(21)13-4-7-26-10-17(13)33-11-12-6-9-32-12/h2-4,7,10,12,28-29H,5-6,8-9,11H2,1H3,(H,27,30)	UJVFITZVZXBDFT-UHFFFAOYSA-N	696431	3-(3-chloro-4-fluoro-2-methoxyanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 13	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.852							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696431	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696431&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445759	COc1c(Cl)c(F)ccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H22ClFN4O4/c1-31-22-16(3-2-14(25)19(22)24)29-21-18-15(5-8-27-23(18)30)28-20(21)13-4-7-26-10-17(13)33-11-12-6-9-32-12/h2-4,7,10,12,28-29H,5-6,8-9,11H2,1H3,(H,27,30)	UJVFITZVZXBDFT-UHFFFAOYSA-N	696432	(&#8722;)-3-(3-chloro-4-fluoro-2-methoxyanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 14	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 15.6							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696432	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696432&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445760	COc1c(Cl)c(F)ccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H22ClFN4O4/c1-31-22-16(3-2-14(25)19(22)24)29-21-18-15(5-8-27-23(18)30)28-20(21)13-4-7-26-10-17(13)33-11-12-6-9-32-12/h2-4,7,10,12,28-29H,5-6,8-9,11H2,1H3,(H,27,30)	UJVFITZVZXBDFT-UHFFFAOYSA-N	696433	(+)-3-(3-chloro-4-fluoro-2-methoxyanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 15	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		<0.073							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696433	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696433&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445761	Fc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2COC2)c1Cl	InChI=1S/C22H20ClFN4O3/c23-19-14(24)2-1-3-16(19)28-21-18-15(5-7-26-22(18)29)27-20(21)13-4-6-25-8-17(13)31-11-12-9-30-10-12/h1-4,6,8,12,27-28H,5,7,9-11H2,(H,26,29)	GYAMIWHHJCCHMA-UHFFFAOYSA-N	696434	3-(2-chloro-3-fluoroanilino)-2-{3-[(oxetan-3-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 16	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.099							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696434	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696434&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445762	FC(F)Oc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1COC1	InChI=1S/C23H21ClF2N4O4/c24-14-2-1-3-16(21(14)34-23(25)26)30-20-18-15(5-7-28-22(18)31)29-19(20)13-4-6-27-8-17(13)33-11-12-9-32-10-12/h1-4,6,8,12,23,29-30H,5,7,9-11H2,(H,28,31)	GVKHRVZRXZDMHO-UHFFFAOYSA-N	696435	3-[3-chloro-2-(difluoromethoxy)anilino]-2-{3-[(oxetan-3-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 17	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.110							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696435	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696435&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445763	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1COC1	InChI=1S/C23H23FN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-8-26-23(19)29)27-20(21)14-5-7-25-9-18(14)32-12-13-10-31-11-13/h2-5,7,9,13,27-28H,6,8,10-12H2,1H3,(H,26,29)	UUCWDVRQAYLICE-UHFFFAOYSA-N	696436	3-(3-fluoro-2-methoxyanilino)-2-{3-[(oxetan-3-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 18	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.239							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696436	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696436&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445764	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25FN4O4/c1-24(8-11-33-24)13-32-18-12-26-9-6-14(18)20-21(19-16(28-20)7-10-27-23(19)30)29-17-5-3-4-15(25)22(17)31-2/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	DJTUCMZNDSOZGL-UHFFFAOYSA-N	696437	3-(3-fluoro-2-methoxyanilino)-2-{3-[(2-methyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 19	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.115							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696437	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696437&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445765	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25FN4O4/c1-24(8-11-33-24)13-32-18-12-26-9-6-14(18)20-21(19-16(28-20)7-10-27-23(19)30)29-17-5-3-4-15(25)22(17)31-2/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	DJTUCMZNDSOZGL-UHFFFAOYSA-N	696438	(&#8722;)-3-(3-fluoro-2-methoxyanilino)-2-{3-[(2-methyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 20	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.923							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696438	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696438&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445766	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25FN4O4/c1-24(8-11-33-24)13-32-18-12-26-9-6-14(18)20-21(19-16(28-20)7-10-27-23(19)30)29-17-5-3-4-15(25)22(17)31-2/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	DJTUCMZNDSOZGL-UHFFFAOYSA-N	696439	(+)-3-(3-fluoro-2-methoxyanilino)-2-{3-[(2-methyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 21	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		<0.073							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696439	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696439&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445767	CCC1(COc2cnccc2-c2[nH]c3CCNC(=O)c3c2Nc2cccc(Cl)c2OC)COC1	InChI=1S/C25H27ClN4O4/c1-3-25(12-33-13-25)14-34-19-11-27-9-7-15(19)21-22(20-17(29-21)8-10-28-24(20)31)30-18-6-4-5-16(26)23(18)32-2/h4-7,9,11,29-30H,3,8,10,12-14H2,1-2H3,(H,28,31)	NUECLEPNQGICPE-UHFFFAOYSA-N	696440	3-(3-chloro-2-methoxyanilino)-2-{3-[(3-ethyloxetan-3-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 22	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.114							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696440	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696440&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445768	CCC1(COc2cnccc2-c2[nH]c3CCNC(=O)c3c2Nc2cccc(Cl)c2C)COC1	InChI=1S/C25H27ClN4O3/c1-3-25(12-32-13-25)14-33-20-11-27-9-7-16(20)22-23(21-19(30-22)8-10-28-24(21)31)29-18-6-4-5-17(26)15(18)2/h4-7,9,11,29-30H,3,8,10,12-14H2,1-2H3,(H,28,31)	DQOVJQWXVRQTTM-UHFFFAOYSA-N	696441	3-(3-chloro-2-methylanilino)-2-{3-[(3-ethyloxetan-3-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 23	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.960							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696441	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696441&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445769	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCCC1CCO1	InChI=1S/C24H25ClN4O4/c1-31-23-16(25)3-2-4-18(23)29-22-20-17(6-10-27-24(20)30)28-21(22)15-5-9-26-13-19(15)33-12-8-14-7-11-32-14/h2-5,9,13-14,28-29H,6-8,10-12H2,1H3,(H,27,30)	WRHXCULGAQMZFX-UHFFFAOYSA-N	696442	3-(3-chloro-2-methoxyanilino)-2-{3-[2-(oxetan-2-yl)ethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 24	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.203							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696442	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696442&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445770	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCCC1CCO1	InChI=1S/C24H25ClN4O4/c1-31-23-16(25)3-2-4-18(23)29-22-20-17(6-10-27-24(20)30)28-21(22)15-5-9-26-13-19(15)33-12-8-14-7-11-32-14/h2-5,9,13-14,28-29H,6-8,10-12H2,1H3,(H,27,30)	WRHXCULGAQMZFX-UHFFFAOYSA-N	696443	(+)-3-(3-chloro-2-methoxyanilino)-2-{3-[2-(oxetan-2-yl)ethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 25	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		<0.073							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696443	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696443&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445771	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCCC1CCO1	InChI=1S/C24H25ClN4O4/c1-31-23-16(25)3-2-4-18(23)29-22-20-17(6-10-27-24(20)30)28-21(22)15-5-9-26-13-19(15)33-12-8-14-7-11-32-14/h2-5,9,13-14,28-29H,6-8,10-12H2,1H3,(H,27,30)	WRHXCULGAQMZFX-UHFFFAOYSA-N	696444	(&#8722;)-3-(3-chloro-2-methoxyanilino)-2-{3-[2-(oxetan-2-yl)ethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 26	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		<0.073							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696444	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696444&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445772	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@@H]1CCN1C |r|	InChI=1S/C24H26ClN5O3/c1-30-11-8-14(30)13-33-19-12-26-9-6-15(19)21-22(20-17(28-21)7-10-27-24(20)31)29-18-5-3-4-16(25)23(18)32-2/h3-6,9,12,14,28-29H,7-8,10-11,13H2,1-2H3,(H,27,31)	XAOLPFSIXBPUKD-UHFFFAOYSA-N	696445	3-(3-chloro-2-methoxyanilino)-2-(3-{[(2S)-1-methylazetidin-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 27	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.445							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696445	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696445&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445773	CCN1CC[C@H]1COc1cnccc1-c1[nH]c2CCNC(=O)c2c1Nc1cccc(Cl)c1OC |r|	InChI=1S/C25H28ClN5O3/c1-3-31-12-9-15(31)14-34-20-13-27-10-7-16(20)22-23(21-18(29-22)8-11-28-25(21)32)30-19-6-4-5-17(26)24(19)33-2/h4-7,10,13,15,29-30H,3,8-9,11-12,14H2,1-2H3,(H,28,32)	VPLNFQDAWVGFIK-UHFFFAOYSA-N	696446	3-(3-chloro-2-methoxyanilino)-2-(3-{[(2S)-1-ethylazetidin-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 28	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 1.06							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696446	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696446&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445774	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@@H]1CCN1CC(F)(F)F |r|	InChI=1S/C25H25ClF3N5O3/c1-36-23-16(26)3-2-4-18(23)33-22-20-17(6-9-31-24(20)35)32-21(22)15-5-8-30-11-19(15)37-12-14-7-10-34(14)13-25(27,28)29/h2-5,8,11,14,32-33H,6-7,9-10,12-13H2,1H3,(H,31,35)	JGQDKIHXHXLKBY-UHFFFAOYSA-N	696447	3-(3-chloro-2-methoxyanilino)-2-(3-{[(2S)-1-(2,2,2-trifluoroethyl)azetidin-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 29	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.304							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696447	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696447&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445775	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@H]1CCN1CC(F)(F)F |r|	InChI=1S/C25H25ClF3N5O3/c1-36-23-16(26)3-2-4-18(23)33-22-20-17(6-9-31-24(20)35)32-21(22)15-5-8-30-11-19(15)37-12-14-7-10-34(14)13-25(27,28)29/h2-5,8,11,14,32-33H,6-7,9-10,12-13H2,1H3,(H,31,35)	JGQDKIHXHXLKBY-UHFFFAOYSA-N	696448	3-(3-chloro-2-methoxyanilino)-2-(3-{[(2R)-1-(2,2,2-trifluoroethyl)azetidin-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 30	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.346							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696448	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696448&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445776	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCN1C	InChI=1S/C25H28ClN5O3/c1-25(9-12-31(25)2)14-34-19-13-27-10-7-15(19)21-22(20-17(29-21)8-11-28-24(20)32)30-18-6-4-5-16(26)23(18)33-3/h4-7,10,13,29-30H,8-9,11-12,14H2,1-3H3,(H,28,32)	SKALBELAOWOPIC-UHFFFAOYSA-N	696449	3-(3-chloro-2-methoxyanilino)-2-{3-[(1,2-dimethylazetidin-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 31	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 1.04							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696449	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696449&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445777	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCN1CC(F)(F)F	InChI=1S/C26H27ClF3N5O3/c1-25(8-11-35(25)13-26(28,29)30)14-38-19-12-31-9-6-15(19)21-22(20-17(33-21)7-10-32-24(20)36)34-18-5-3-4-16(27)23(18)37-2/h3-6,9,12,33-34H,7-8,10-11,13-14H2,1-2H3,(H,32,36)	AAWSCNSGDWBYRL-UHFFFAOYSA-N	696450	3-(3-chloro-2-methoxyanilino)-2-(3-{[2-methyl-1-(2,2,2-trifluoroethyl)azetidin-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 32	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.359							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696450	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696450&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445778	COc1c(Br)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H23BrN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-9-26-23(19)29)27-20(21)14-5-8-25-11-18(14)32-12-13-7-10-31-13/h2-5,8,11,13,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	HSEUQTHBEYTMEG-UHFFFAOYSA-N	696451	US20240307362, Example 33::3-(3-bromo-2-methoxyanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1, 5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 34::US20240307362, Example 35	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.142							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696451	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696451&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445779	COc1c(Br)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H23BrN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-9-26-23(19)29)27-20(21)14-5-8-25-11-18(14)32-12-13-7-10-31-13/h2-5,8,11,13,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	HSEUQTHBEYTMEG-UHFFFAOYSA-N	696451	US20240307362, Example 33::3-(3-bromo-2-methoxyanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1, 5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 34::US20240307362, Example 35	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.157							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696451	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696451&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445780	COc1c(Br)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H23BrN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-9-26-23(19)29)27-20(21)14-5-8-25-11-18(14)32-12-13-7-10-31-13/h2-5,8,11,13,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	HSEUQTHBEYTMEG-UHFFFAOYSA-N	696451	US20240307362, Example 33::3-(3-bromo-2-methoxyanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1, 5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 34::US20240307362, Example 35	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.278							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696451	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696451&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445781	O=C1NCCc2[nH]c(c(Nc3cccc4CCCc34)c12)-c1ccncc1OCC1CCO1	InChI=1S/C25H26N4O3/c30-25-22-20(8-11-27-25)29-23(18-7-10-26-13-21(18)32-14-16-9-12-31-16)24(22)28-19-6-2-4-15-3-1-5-17(15)19/h2,4,6-7,10,13,16,28-29H,1,3,5,8-9,11-12,14H2,(H,27,30)	JRQXKSFDCJJOHX-UHFFFAOYSA-N	696454	3-[(2,3-dihydro-1H-inden-4-yl)amino]-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 36	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.726							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696454	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696454&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445782	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2CCO2)c1Cl	InChI=1S/C23H23ClN4O3/c1-13-3-2-4-17(20(13)24)28-22-19-16(6-9-26-23(19)29)27-21(22)15-5-8-25-11-18(15)31-12-14-7-10-30-14/h2-5,8,11,14,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	HXYQNURBSWYMIH-UHFFFAOYSA-N	696455	3-(2-chloro-3-methylanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 37	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.129							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696455	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696455&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445783	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2CCO2)c1Cl	InChI=1S/C23H23ClN4O3/c1-13-3-2-4-17(20(13)24)28-22-19-16(6-9-26-23(19)29)27-21(22)15-5-8-25-11-18(15)31-12-14-7-10-30-14/h2-5,8,11,14,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	HXYQNURBSWYMIH-UHFFFAOYSA-N	696456	(+)-3-(2-chloro-3-methylanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 38	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.134							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696456	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696456&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445784	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2CCO2)c1Cl	InChI=1S/C23H23ClN4O3/c1-13-3-2-4-17(20(13)24)28-22-19-16(6-9-26-23(19)29)27-21(22)15-5-8-25-11-18(15)31-12-14-7-10-30-14/h2-5,8,11,14,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	HXYQNURBSWYMIH-UHFFFAOYSA-N	696457	(&#8722;)-3-(2-chloro-3-methylanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 39	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.393							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696457	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696457&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445785	Cc1c(Cl)cc(F)cc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H22ClFN4O3/c1-12-16(24)8-13(25)9-18(12)29-22-20-17(3-6-27-23(20)30)28-21(22)15-2-5-26-10-19(15)32-11-14-4-7-31-14/h2,5,8-10,14,28-29H,3-4,6-7,11H2,1H3,(H,27,30)	LZXZTUZMADCWEL-UHFFFAOYSA-N	696458	US20240307362, Example 40::US20240307362, Example 41::US20240307362, Example 42::3-(3-chloro-5-fluoro-2-methylanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.240							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696458	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696458&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445786	Cc1c(Cl)cc(F)cc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H22ClFN4O3/c1-12-16(24)8-13(25)9-18(12)29-22-20-17(3-6-27-23(20)30)28-21(22)15-2-5-26-10-19(15)32-11-14-4-7-31-14/h2,5,8-10,14,28-29H,3-4,6-7,11H2,1H3,(H,27,30)	LZXZTUZMADCWEL-UHFFFAOYSA-N	696458	US20240307362, Example 40::US20240307362, Example 41::US20240307362, Example 42::3-(3-chloro-5-fluoro-2-methylanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 2.18							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696458	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696458&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445787	Cc1c(Cl)cc(F)cc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H22ClFN4O3/c1-12-16(24)8-13(25)9-18(12)29-22-20-17(3-6-27-23(20)30)28-21(22)15-2-5-26-10-19(15)32-11-14-4-7-31-14/h2,5,8-10,14,28-29H,3-4,6-7,11H2,1H3,(H,27,30)	LZXZTUZMADCWEL-UHFFFAOYSA-N	696458	US20240307362, Example 40::US20240307362, Example 41::US20240307362, Example 42::3-(3-chloro-5-fluoro-2-methylanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.089							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696458	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696458&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445788	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCCC1CCO1	InChI=1S/C24H25FN4O4/c1-31-23-16(25)3-2-4-18(23)29-22-20-17(6-10-27-24(20)30)28-21(22)15-5-9-26-13-19(15)33-12-8-14-7-11-32-14/h2-5,9,13-14,28-29H,6-8,10-12H2,1H3,(H,27,30)	ODAIREHMFFYMSF-UHFFFAOYSA-N	696461	US20240307362, Example 43::3-(3-fluoro-2-methoxyanilino)-2-{3-[2-(oxetan-2-yl)ethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 44::US20240307362, Example 45	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		<0.073							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696461	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696461&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445789	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCCC1CCO1	InChI=1S/C24H25FN4O4/c1-31-23-16(25)3-2-4-18(23)29-22-20-17(6-10-27-24(20)30)28-21(22)15-5-9-26-13-19(15)33-12-8-14-7-11-32-14/h2-5,9,13-14,28-29H,6-8,10-12H2,1H3,(H,27,30)	ODAIREHMFFYMSF-UHFFFAOYSA-N	696461	US20240307362, Example 43::3-(3-fluoro-2-methoxyanilino)-2-{3-[2-(oxetan-2-yl)ethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 44::US20240307362, Example 45	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.221							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696461	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696461&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445790	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCCC1CCO1	InChI=1S/C24H25FN4O4/c1-31-23-16(25)3-2-4-18(23)29-22-20-17(6-10-27-24(20)30)28-21(22)15-5-9-26-13-19(15)33-12-8-14-7-11-32-14/h2-5,9,13-14,28-29H,6-8,10-12H2,1H3,(H,27,30)	ODAIREHMFFYMSF-UHFFFAOYSA-N	696461	US20240307362, Example 43::3-(3-fluoro-2-methoxyanilino)-2-{3-[2-(oxetan-2-yl)ethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 44::US20240307362, Example 45	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.302							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696461	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696461&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445791	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25ClN4O4/c1-24(8-11-33-24)13-32-18-12-26-9-6-14(18)20-21(19-16(28-20)7-10-27-23(19)30)29-17-5-3-4-15(25)22(17)31-2/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	WAYAVZXSRJPQKW-UHFFFAOYSA-N	696464	3-(3-chloro-2-methoxyanilino)-2-{3-[(2-methyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 46	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.111							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696464	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696464&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445792	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25ClN4O4/c1-24(8-11-33-24)13-32-18-12-26-9-6-14(18)20-21(19-16(28-20)7-10-27-23(19)30)29-17-5-3-4-15(25)22(17)31-2/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	WAYAVZXSRJPQKW-UHFFFAOYSA-N	696465	(&#8722;)-3-(3-chloro-2-methoxyanilino)-2-{3-[(2-methyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 47	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.127							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696465	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696465&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445793	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25ClN4O4/c1-24(8-11-33-24)13-32-18-12-26-9-6-14(18)20-21(19-16(28-20)7-10-27-23(19)30)29-17-5-3-4-15(25)22(17)31-2/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	WAYAVZXSRJPQKW-UHFFFAOYSA-N	696466	(+)-3-(3-chloro-2-methoxyanilino)-2-{3-[(2-methyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 48	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.131							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696466	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696466&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445794	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1OCC1(C)C	InChI=1S/C25H27ClN4O4/c1-25(2)13-34-19(25)12-33-18-11-27-9-7-14(18)21-22(20-16(29-21)8-10-28-24(20)31)30-17-6-4-5-15(26)23(17)32-3/h4-7,9,11,19,29-30H,8,10,12-13H2,1-3H3,(H,28,31)	NNFFVTYHPCQYJN-UHFFFAOYSA-N	696467	3-(3-chloro-2-methoxyanilino)-2-{3-[(3,3-dimethyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 49	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.103							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696467	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696467&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445795	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1OCC1(C)C	InChI=1S/C25H27ClN4O4/c1-25(2)13-34-19(25)12-33-18-11-27-9-7-14(18)21-22(20-16(29-21)8-10-28-24(20)31)30-17-6-4-5-15(26)23(17)32-3/h4-7,9,11,19,29-30H,8,10,12-13H2,1-3H3,(H,28,31)	NNFFVTYHPCQYJN-UHFFFAOYSA-N	696468	(+)-3-(3-chloro-2-methoxyanilino)-2-{3-[(3,3-dimethyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 50	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.207							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696468	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696468&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445796	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1OCC1(C)C	InChI=1S/C25H27ClN4O4/c1-25(2)13-34-19(25)12-33-18-11-27-9-7-14(18)21-22(20-16(29-21)8-10-28-24(20)31)30-17-6-4-5-15(26)23(17)32-3/h4-7,9,11,19,29-30H,8,10,12-13H2,1-3H3,(H,28,31)	NNFFVTYHPCQYJN-UHFFFAOYSA-N	696469	(&#8722;)-3-(3-chloro-2-methoxyanilino)-2-{3-[(3,3-dimethyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 51	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.252							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696469	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696469&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445797	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1OCC1(C)C	InChI=1S/C25H27FN4O4/c1-25(2)13-34-19(25)12-33-18-11-27-9-7-14(18)21-22(20-16(29-21)8-10-28-24(20)31)30-17-6-4-5-15(26)23(17)32-3/h4-7,9,11,19,29-30H,8,10,12-13H2,1-3H3,(H,28,31)	BJCRYONAAUDYKC-UHFFFAOYSA-N	696470	2-{3-[(3,3-dimethyloxetan-2-yl)methoxy]pyridin-4-yl}-3-(3-fluoro-2-methoxyanilino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 52	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		<0.073							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696470	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696470&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445798	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1OCC1(C)C	InChI=1S/C25H27FN4O4/c1-25(2)13-34-19(25)12-33-18-11-27-9-7-14(18)21-22(20-16(29-21)8-10-28-24(20)31)30-17-6-4-5-15(26)23(17)32-3/h4-7,9,11,19,29-30H,8,10,12-13H2,1-3H3,(H,28,31)	BJCRYONAAUDYKC-UHFFFAOYSA-N	696471	(&#8722;)-2-{3-[(3,3-dimethyloxetan-2-yl)methoxy]pyridin-4-yl}-3-(3-fluoro-2-methoxyanilino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 53	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.508							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696471	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696471&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445799	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1OCC1(C)C	InChI=1S/C25H27FN4O4/c1-25(2)13-34-19(25)12-33-18-11-27-9-7-14(18)21-22(20-16(29-21)8-10-28-24(20)31)30-17-6-4-5-15(26)23(17)32-3/h4-7,9,11,19,29-30H,8,10,12-13H2,1-3H3,(H,28,31)	BJCRYONAAUDYKC-UHFFFAOYSA-N	696472	(+)-2-{3-[(3,3-dimethyloxetan-2-yl)methoxy]pyridin-4-yl}-3-(3-fluoro-2-methoxyanilino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 54	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.164							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696472	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696472&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445800	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2(C)CCO2)c1Cl	InChI=1S/C24H25ClN4O3/c1-14-4-3-5-17(20(14)25)29-22-19-16(7-10-27-23(19)30)28-21(22)15-6-9-26-12-18(15)31-13-24(2)8-11-32-24/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	RBTLEYBFYMGLPY-UHFFFAOYSA-N	696473	3-(2-chloro-3-methylanilino)-2-{3-[(2-methyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 55	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.138							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696473	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696473&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445801	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2(C)CCO2)c1Cl	InChI=1S/C24H25ClN4O3/c1-14-4-3-5-17(20(14)25)29-22-19-16(7-10-27-23(19)30)28-21(22)15-6-9-26-12-18(15)31-13-24(2)8-11-32-24/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	RBTLEYBFYMGLPY-UHFFFAOYSA-N	696474	(+)-3-(2-chloro-3-methylanilino)-2-{3-[(2-methyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 56	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.150							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696474	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696474&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445802	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2(C)CCO2)c1Cl	InChI=1S/C24H25ClN4O3/c1-14-4-3-5-17(20(14)25)29-22-19-16(7-10-27-23(19)30)28-21(22)15-6-9-26-12-18(15)31-13-24(2)8-11-32-24/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	RBTLEYBFYMGLPY-UHFFFAOYSA-N	696475	(&#8722;)-3-(2-chloro-3-methylanilino)-2-{3-[(2-methyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 57	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.264							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696475	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696475&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445803	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2OCC2(C)C)c1Cl	InChI=1S/C25H27ClN4O3/c1-14-5-4-6-17(21(14)26)30-23-20-16(8-10-28-24(20)31)29-22(23)15-7-9-27-11-18(15)32-12-19-25(2,3)13-33-19/h4-7,9,11,19,29-30H,8,10,12-13H2,1-3H3,(H,28,31)	IWYZJYOKHWHOBO-UHFFFAOYSA-N	696476	3-(2-chloro-3-methylanilino)-2-{3-[(3,3-dimethyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 58	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		<0.073							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696476	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696476&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445804	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2OCC2(C)C)c1Cl	InChI=1S/C25H27ClN4O3/c1-14-5-4-6-17(21(14)26)30-23-20-16(8-10-28-24(20)31)29-22(23)15-7-9-27-11-18(15)32-12-19-25(2,3)13-33-19/h4-7,9,11,19,29-30H,8,10,12-13H2,1-3H3,(H,28,31)	IWYZJYOKHWHOBO-UHFFFAOYSA-N	696477	(+)-3-(2-chloro-3-methylanilino)-2-{3-[(3,3-dimethyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 59	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.214							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696477	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696477&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445805	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2OCC2(C)C)c1Cl	InChI=1S/C25H27ClN4O3/c1-14-5-4-6-17(21(14)26)30-23-20-16(8-10-28-24(20)31)29-22(23)15-7-9-27-11-18(15)32-12-19-25(2,3)13-33-19/h4-7,9,11,19,29-30H,8,10,12-13H2,1-3H3,(H,28,31)	IWYZJYOKHWHOBO-UHFFFAOYSA-N	696478	(&#8722;)-3-(2-chloro-3-methylanilino)-2-{3-[(3,3-dimethyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 60	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.855							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696478	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696478&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445806	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(F)COC1	InChI=1S/C23H22F2N4O4/c1-31-21-14(24)3-2-4-16(21)29-20-18-15(6-8-27-22(18)30)28-19(20)13-5-7-26-9-17(13)33-12-23(25)10-32-11-23/h2-5,7,9,28-29H,6,8,10-12H2,1H3,(H,27,30)	JBEIWZWWBOIWRA-UHFFFAOYSA-N	696479	3-(3-fluoro-2-methoxyanilino)-2-{3-[(3-fluorooxetan-3-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 61	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.332							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696479	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696479&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445807	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCCC2CCO2)c1Cl	InChI=1S/C24H25ClN4O3/c1-14-3-2-4-18(21(14)25)29-23-20-17(6-10-27-24(20)30)28-22(23)16-5-9-26-13-19(16)32-12-8-15-7-11-31-15/h2-5,9,13,15,28-29H,6-8,10-12H2,1H3,(H,27,30)	QZQGIDLXPFWWKW-UHFFFAOYSA-N	696480	3-(2-chloro-3-methylanilino)-2-{3-[2-(oxetan-2-yl)ethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 62	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.295							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696480	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696480&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445808	Clc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCCC2CCO2)c1Cl	InChI=1S/C23H22Cl2N4O3/c24-15-2-1-3-17(20(15)25)29-22-19-16(5-9-27-23(19)30)28-21(22)14-4-8-26-12-18(14)32-11-7-13-6-10-31-13/h1-4,8,12-13,28-29H,5-7,9-11H2,(H,27,30)	PBJQSVYLISRMDO-UHFFFAOYSA-N	696481	US20240307362, Example 63::3-(2,3-dichloroanilino)-2-(3-{2-[oxetan-2-yl]ethoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 64	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.123							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696481	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696481&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445809	Clc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCCC2CCO2)c1Cl	InChI=1S/C23H22Cl2N4O3/c24-15-2-1-3-17(20(15)25)29-22-19-16(5-9-27-23(19)30)28-21(22)14-4-8-26-12-18(14)32-11-7-13-6-10-31-13/h1-4,8,12-13,28-29H,5-7,9-11H2,(H,27,30)	PBJQSVYLISRMDO-UHFFFAOYSA-N	696481	US20240307362, Example 63::3-(2,3-dichloroanilino)-2-(3-{2-[oxetan-2-yl]ethoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 64	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.130							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696481	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696481&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445810	COc1c(Cl)cc(F)cc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H22ClFN4O4/c1-31-22-15(24)8-12(25)9-17(22)29-21-19-16(3-6-27-23(19)30)28-20(21)14-2-5-26-10-18(14)33-11-13-4-7-32-13/h2,5,8-10,13,28-29H,3-4,6-7,11H2,1H3,(H,27,30)	FLRRWFWNBSISCE-UHFFFAOYSA-N	696483	US20240307362, Example 65::3-(3-chloro-5-fluoro-2-methoxyanilino)-2-(3-{[oxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 66::US20240307362, Example 67	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.176							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696483	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696483&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445811	COc1c(Cl)cc(F)cc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H22ClFN4O4/c1-31-22-15(24)8-12(25)9-17(22)29-21-19-16(3-6-27-23(19)30)28-20(21)14-2-5-26-10-18(14)33-11-13-4-7-32-13/h2,5,8-10,13,28-29H,3-4,6-7,11H2,1H3,(H,27,30)	FLRRWFWNBSISCE-UHFFFAOYSA-N	696483	US20240307362, Example 65::3-(3-chloro-5-fluoro-2-methoxyanilino)-2-(3-{[oxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 66::US20240307362, Example 67	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.471							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696483	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696483&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445812	COc1c(Cl)cc(F)cc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H22ClFN4O4/c1-31-22-15(24)8-12(25)9-17(22)29-21-19-16(3-6-27-23(19)30)28-20(21)14-2-5-26-10-18(14)33-11-13-4-7-32-13/h2,5,8-10,13,28-29H,3-4,6-7,11H2,1H3,(H,27,30)	FLRRWFWNBSISCE-UHFFFAOYSA-N	696483	US20240307362, Example 65::3-(3-chloro-5-fluoro-2-methoxyanilino)-2-(3-{[oxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 66::US20240307362, Example 67	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 1.74							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696483	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696483&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445813	COc1c(Cl)cc(F)cc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H24ClFN4O4/c1-24(5-8-34-24)12-33-18-11-27-6-3-14(18)20-21(19-16(29-20)4-7-28-23(19)31)30-17-10-13(26)9-15(25)22(17)32-2/h3,6,9-11,29-30H,4-5,7-8,12H2,1-2H3,(H,28,31)	VELMTONNZHUPQP-UHFFFAOYSA-N	696486	US20240307362, Example 68::US20240307362, Example 70::3-(3-chloro-5-fluoro-2-methoxyanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 69	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.215							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696486	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696486&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445814	COc1c(Cl)cc(F)cc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H24ClFN4O4/c1-24(5-8-34-24)12-33-18-11-27-6-3-14(18)20-21(19-16(29-20)4-7-28-23(19)31)30-17-10-13(26)9-15(25)22(17)32-2/h3,6,9-11,29-30H,4-5,7-8,12H2,1-2H3,(H,28,31)	VELMTONNZHUPQP-UHFFFAOYSA-N	696486	US20240307362, Example 68::US20240307362, Example 70::3-(3-chloro-5-fluoro-2-methoxyanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 69	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.317							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696486	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696486&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445815	COc1c(Cl)cc(F)cc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H24ClFN4O4/c1-24(5-8-34-24)12-33-18-11-27-6-3-14(18)20-21(19-16(29-20)4-7-28-23(19)31)30-17-10-13(26)9-15(25)22(17)32-2/h3,6,9-11,29-30H,4-5,7-8,12H2,1-2H3,(H,28,31)	VELMTONNZHUPQP-UHFFFAOYSA-N	696486	US20240307362, Example 68::US20240307362, Example 70::3-(3-chloro-5-fluoro-2-methoxyanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 69	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.161							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696486	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696486&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445816	CC1(C)COC1COc1cnccc1-c1[nH]c2CCNC(=O)c2c1Nc1cccc(Cl)c1OC(F)F	InChI=1S/C25H25ClF2N4O4/c1-25(2)12-35-18(25)11-34-17-10-29-8-6-13(17)20-21(19-15(31-20)7-9-30-23(19)33)32-16-5-3-4-14(26)22(16)36-24(27)28/h3-6,8,10,18,24,31-32H,7,9,11-12H2,1-2H3,(H,30,33)	RTFDMXFTQZCKAO-UHFFFAOYSA-N	696489	US20240307362, Example 71::US20240307362, Example 72::US20240307362, Example 73::3-[3-chloro-2-(difluoromethoxy)anilino]-2-(3-{[3,3-dimethyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.208							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696489	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696489&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445817	CC1(C)COC1COc1cnccc1-c1[nH]c2CCNC(=O)c2c1Nc1cccc(Cl)c1OC(F)F	InChI=1S/C25H25ClF2N4O4/c1-25(2)12-35-18(25)11-34-17-10-29-8-6-13(17)20-21(19-15(31-20)7-9-30-23(19)33)32-16-5-3-4-14(26)22(16)36-24(27)28/h3-6,8,10,18,24,31-32H,7,9,11-12H2,1-2H3,(H,30,33)	RTFDMXFTQZCKAO-UHFFFAOYSA-N	696489	US20240307362, Example 71::US20240307362, Example 72::US20240307362, Example 73::3-[3-chloro-2-(difluoromethoxy)anilino]-2-(3-{[3,3-dimethyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 1.54							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696489	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696489&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445818	CC1(C)COC1COc1cnccc1-c1[nH]c2CCNC(=O)c2c1Nc1cccc(Cl)c1OC(F)F	InChI=1S/C25H25ClF2N4O4/c1-25(2)12-35-18(25)11-34-17-10-29-8-6-13(17)20-21(19-15(31-20)7-9-30-23(19)33)32-16-5-3-4-14(26)22(16)36-24(27)28/h3-6,8,10,18,24,31-32H,7,9,11-12H2,1-2H3,(H,30,33)	RTFDMXFTQZCKAO-UHFFFAOYSA-N	696489	US20240307362, Example 71::US20240307362, Example 72::US20240307362, Example 73::3-[3-chloro-2-(difluoromethoxy)anilino]-2-(3-{[3,3-dimethyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.526							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696489	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696489&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445819	CC1(COc2cnccc2-c2[nH]c3CCNC(=O)c3c2Nc2cccc(Cl)c2OC(F)F)CCO1	InChI=1S/C24H23ClF2N4O4/c1-24(7-10-34-24)12-33-17-11-28-8-5-13(17)19-20(18-15(30-19)6-9-29-22(18)32)31-16-4-2-3-14(25)21(16)35-23(26)27/h2-5,8,11,23,30-31H,6-7,9-10,12H2,1H3,(H,29,32)	DBSFBNGNNCTWKI-UHFFFAOYSA-N	696492	US20240307362, Example 74::US20240307362, Example 75::3-[3-chloro-2-(difluoromethoxy)anilino]-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 76	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.282							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696492	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696492&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445820	CC1(COc2cnccc2-c2[nH]c3CCNC(=O)c3c2Nc2cccc(Cl)c2OC(F)F)CCO1	InChI=1S/C24H23ClF2N4O4/c1-24(7-10-34-24)12-33-17-11-28-8-5-13(17)19-20(18-15(30-19)6-9-29-22(18)32)31-16-4-2-3-14(25)21(16)35-23(26)27/h2-5,8,11,23,30-31H,6-7,9-10,12H2,1H3,(H,29,32)	DBSFBNGNNCTWKI-UHFFFAOYSA-N	696492	US20240307362, Example 74::US20240307362, Example 75::3-[3-chloro-2-(difluoromethoxy)anilino]-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 76	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.241							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696492	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696492&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445821	CC1(COc2cnccc2-c2[nH]c3CCNC(=O)c3c2Nc2cccc(Cl)c2OC(F)F)CCO1	InChI=1S/C24H23ClF2N4O4/c1-24(7-10-34-24)12-33-17-11-28-8-5-13(17)19-20(18-15(30-19)6-9-29-22(18)32)31-16-4-2-3-14(25)21(16)35-23(26)27/h2-5,8,11,23,30-31H,6-7,9-10,12H2,1H3,(H,29,32)	DBSFBNGNNCTWKI-UHFFFAOYSA-N	696492	US20240307362, Example 74::US20240307362, Example 75::3-[3-chloro-2-(difluoromethoxy)anilino]-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 76	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.290							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696492	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696492&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445822	CCc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C24H25ClN4O3/c1-2-15-17(25)4-3-5-18(15)28-23-21-19(7-10-27-24(21)30)29-22(23)16-6-9-26-12-20(16)32-13-14-8-11-31-14/h3-6,9,12,14,28-29H,2,7-8,10-11,13H2,1H3,(H,27,30)	MLABNBQNHFFTEX-UHFFFAOYSA-N	696495	3-(3-chloro-2-ethylanilino)-2-(3-{[oxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 77	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.281							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696495	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696495&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445823	CCc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C25H27ClN4O3/c1-3-15-17(26)5-4-6-18(15)29-23-21-19(8-11-28-24(21)31)30-22(23)16-7-10-27-13-20(16)32-14-25(2)9-12-33-25/h4-7,10,13,29-30H,3,8-9,11-12,14H2,1-2H3,(H,28,31)	FRDBERWGGHAWIN-UHFFFAOYSA-N	696496	3-(3-chloro-2-ethylanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 78	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.267							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696496	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696496&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445824	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@H]1CCN1C |r|	InChI=1S/C24H26FN5O3/c1-30-11-8-14(30)13-33-19-12-26-9-6-15(19)21-22(20-17(28-21)7-10-27-24(20)31)29-18-5-3-4-16(25)23(18)32-2/h3-6,9,12,14,28-29H,7-8,10-11,13H2,1-2H3,(H,27,31)	QVGPGCWVZNRVHU-UHFFFAOYSA-N	696497	3-(3-fluoro-2-methoxyanilino)-2-(3-{[(2R)-1-methylazetidin-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 79	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.718							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696497	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696497&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445825	Cc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25ClN4O3/c1-14-16(25)4-3-5-17(14)28-22-20-18(7-10-27-23(20)30)29-21(22)15-6-9-26-12-19(15)31-13-24(2)8-11-32-24/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	HAZKVKWVLOVCKD-UHFFFAOYSA-N	696498	US20240307362, Example 80::3-(3-chloro-2-methylanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 81	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.187							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696498	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696498&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445826	Cc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25ClN4O3/c1-14-16(25)4-3-5-17(14)28-22-20-18(7-10-27-23(20)30)29-21(22)15-6-9-26-12-19(15)31-13-24(2)8-11-32-24/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	HAZKVKWVLOVCKD-UHFFFAOYSA-N	696498	US20240307362, Example 80::3-(3-chloro-2-methylanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 81	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.129							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696498	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696498&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445827	Cc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@]1(C)CCO1 |r|	InChI=1S/C24H25ClN4O3/c1-14-16(25)4-3-5-17(14)28-22-20-18(7-10-27-23(20)30)29-21(22)15-6-9-26-12-19(15)31-13-24(2)8-11-32-24/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	HAZKVKWVLOVCKD-UHFFFAOYSA-N	696500	(+)-3-(3-chloro-2-methylanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 82	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.134							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696500	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696500&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445828	Cc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25FN4O3/c1-14-16(25)4-3-5-17(14)28-22-20-18(7-10-27-23(20)30)29-21(22)15-6-9-26-12-19(15)31-13-24(2)8-11-32-24/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	QVHMIYFARBLZEB-UHFFFAOYSA-N	696501	3-(3-fluoro-2-methylanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 83	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.246							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696501	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696501&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445829	Cc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25FN4O3/c1-14-16(25)4-3-5-17(14)28-22-20-18(7-10-27-23(20)30)29-21(22)15-6-9-26-12-19(15)31-13-24(2)8-11-32-24/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	QVHMIYFARBLZEB-UHFFFAOYSA-N	696502	(&#8722;)-3-(3-fluoro-2-methylanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 84	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.156							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696502	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696502&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445830	Cc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25FN4O3/c1-14-16(25)4-3-5-17(14)28-22-20-18(7-10-27-23(20)30)29-21(22)15-6-9-26-12-19(15)31-13-24(2)8-11-32-24/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	QVHMIYFARBLZEB-UHFFFAOYSA-N	696503	(+)-3-(3-fluoro-2-methylanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 85	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.107							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696503	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696503&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445831	CCC1(COc2cnccc2-c2[nH]c3CCNC(=O)c3c2Nc2cccc(C)c2Cl)COC1	InChI=1S/C25H27ClN4O3/c1-3-25(12-32-13-25)14-33-19-11-27-9-7-16(19)22-23(20-17(29-22)8-10-28-24(20)31)30-18-6-4-5-15(2)21(18)26/h4-7,9,11,29-30H,3,8,10,12-14H2,1-2H3,(H,28,31)	DHNUUPBVRMMLTO-UHFFFAOYSA-N	696504	3-(2-chloro-3-methylanilino)-2-{3-[(3-ethyloxetan-3-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 86	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.187							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696504	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696504&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445832	CCC1(COc2cnccc2-c2[nH]c3CCNC(=O)c3c2Nc2cccc(Cl)c2Cl)COC1	InChI=1S/C24H24Cl2N4O3/c1-2-24(11-32-12-24)13-33-18-10-27-8-6-14(18)21-22(19-16(29-21)7-9-28-23(19)31)30-17-5-3-4-15(25)20(17)26/h3-6,8,10,29-30H,2,7,9,11-13H2,1H3,(H,28,31)	SLTMZQMCXDPIIT-UHFFFAOYSA-N	696505	3-(2,3-dichloroanilino)-2-{3-[(3-ethyloxetan-3-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 87	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.135							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696505	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696505&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445833	CCC1(COc2cnccc2-c2[nH]c3CCNC(=O)c3c2Nc2cccc(F)c2OC)COC1	InChI=1S/C25H27FN4O4/c1-3-25(12-33-13-25)14-34-19-11-27-9-7-15(19)21-22(20-17(29-21)8-10-28-24(20)31)30-18-6-4-5-16(26)23(18)32-2/h4-7,9,11,29-30H,3,8,10,12-14H2,1-2H3,(H,28,31)	BCOBOKVIVYIAHU-UHFFFAOYSA-N	696506	2-{3-[(3-ethyloxetan-3-yl)methoxy]pyridin-4-yl}-3-(3-fluoro-2-methoxyanilino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 88	Epidermal growth factor receptor [1-770,'SVD',771-1210]	Homo sapiens		 0.087							US Patent		10.7270/Q2P273NX		aid2060392	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696506	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1252&target=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696506&enzyme=Epidermal+growth+factor+receptor+%5B1-770%2C%27SVD%27%2C771-1210%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDSVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA	7SZ7,7SZ5,7SYE,7SYD,7SZ1,7SZ0,3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,4TKS,1M17,1M14,3VJO,1XKK,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9DM8,9BY6,9BY4,8G63,7T4I,6VHP,6VHN,6VH4,6D8E,5FED,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,9FZS,9FZR,6JZ0,4JRV,4JR3,4JQ8,4JQ7,4LI5	Epidermal growth factor receptor	EGFR_HUMAN	P00533	O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445834	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H23ClN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-9-26-23(19)29)27-20(21)14-5-8-25-11-18(14)32-12-13-7-10-31-13/h2-5,8,11,13,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	AOAHZOQPEJYOCJ-UHFFFAOYSA-N	696414	3-(3-chlor-2-methoxyanilino)-2-[3-(oxetan-2-ylmethoxy)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-on::US20240307362, Example 1	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 10700							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696414	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696414&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445835	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@@H]1CCO1 |r|	InChI=1S/C23H23ClN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-9-26-23(19)29)27-20(21)14-5-8-25-11-18(14)32-12-13-7-10-31-13/h2-5,8,11,13,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	AOAHZOQPEJYOCJ-UHFFFAOYSA-N	696415	3-(3-chlor-2-methoxyanilino)-2-{3-[(2S)-oxetan-2-ylmethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-on::US20240307362, Example 2	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696415	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696415&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445836	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@H]1CCO1 |r|	InChI=1S/C23H23ClN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-9-26-23(19)29)27-20(21)14-5-8-25-11-18(14)32-12-13-7-10-31-13/h2-5,8,11,13,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	AOAHZOQPEJYOCJ-UHFFFAOYSA-N	696421	3-(3-chloro-2-methoxyanilino)-2-(3-{[(2R)-oxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 3	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 4510							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696421	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696421&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445837	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H23FN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-9-26-23(19)29)27-20(21)14-5-8-25-11-18(14)32-12-13-7-10-31-13/h2-5,8,11,13,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	KNPAUZQLPGIQGC-UHFFFAOYSA-N	696422	3-(3-fluoro-2-methoxyanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 4	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 17400							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696422	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696422&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445838	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@@H]1CCO1 |r|	InChI=1S/C23H23FN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-9-26-23(19)29)27-20(21)14-5-8-25-11-18(14)32-12-13-7-10-31-13/h2-5,8,11,13,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	KNPAUZQLPGIQGC-UHFFFAOYSA-N	696423	3-(3-fluoro-2-methoxyanilino)-2-(3-{[(2S)-oxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 5	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696423	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696423&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445839	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@H]1CCO1 |r|	InChI=1S/C23H23FN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-9-26-23(19)29)27-20(21)14-5-8-25-11-18(14)32-12-13-7-10-31-13/h2-5,8,11,13,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	KNPAUZQLPGIQGC-UHFFFAOYSA-N	696424	3-(3-fluoro-2-methoxyanilino)-2-(3-{[(2R)-oxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 6	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>13300							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696424	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696424&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445840	Cc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H23ClN4O3/c1-13-16(24)3-2-4-17(13)27-22-20-18(6-9-26-23(20)29)28-21(22)15-5-8-25-11-19(15)31-12-14-7-10-30-14/h2-5,8,11,14,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	WULQFTQXGPGDQW-UHFFFAOYSA-N	696425	3-(3-chloro-2-methylanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 7	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 2630							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696425	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696425&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445841	Cc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@@H]1CCO1 |r|	InChI=1S/C23H23ClN4O3/c1-13-16(24)3-2-4-17(13)27-22-20-18(6-9-26-23(20)29)28-21(22)15-5-8-25-11-19(15)31-12-14-7-10-30-14/h2-5,8,11,14,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	WULQFTQXGPGDQW-UHFFFAOYSA-N	696426	3-(3-chloro-2-methylanilino)-2-(3-{[(2S)-oxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 8	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 7610							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696426	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696426&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445842	Cc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@H]1CCO1 |r|	InChI=1S/C23H23ClN4O3/c1-13-16(24)3-2-4-17(13)27-22-20-18(6-9-26-23(20)29)28-21(22)15-5-8-25-11-19(15)31-12-14-7-10-30-14/h2-5,8,11,14,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	WULQFTQXGPGDQW-UHFFFAOYSA-N	696427	3-(3-chloro-2-methylanilino)-2-(3-{[(2R)-oxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 9	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 1570							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696427	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696427&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445843	Clc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2CCO2)c1Cl	InChI=1S/C22H20Cl2N4O3/c23-14-2-1-3-16(19(14)24)28-21-18-15(5-8-26-22(18)29)27-20(21)13-4-7-25-10-17(13)31-11-12-6-9-30-12/h1-4,7,10,12,27-28H,5-6,8-9,11H2,(H,26,29)	FIHUXIWCQZUVOU-UHFFFAOYSA-N	696428	3-(2,3-dichloroanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 10	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 13800							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696428	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696428&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445844	Clc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2CCO2)c1Cl	InChI=1S/C22H20Cl2N4O3/c23-14-2-1-3-16(19(14)24)28-21-18-15(5-8-26-22(18)29)27-20(21)13-4-7-25-10-17(13)31-11-12-6-9-30-12/h1-4,7,10,12,27-28H,5-6,8-9,11H2,(H,26,29)	FIHUXIWCQZUVOU-UHFFFAOYSA-N	696429	(+)-3-(2,3-dichloroanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 11	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696429	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696429&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445845	Clc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2CCO2)c1Cl	InChI=1S/C22H20Cl2N4O3/c23-14-2-1-3-16(19(14)24)28-21-18-15(5-8-26-22(18)29)27-20(21)13-4-7-25-10-17(13)31-11-12-6-9-30-12/h1-4,7,10,12,27-28H,5-6,8-9,11H2,(H,26,29)	FIHUXIWCQZUVOU-UHFFFAOYSA-N	696430	(&#8722;)-3-(2,3-dichloroanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 12	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 11300							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696430	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696430&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445846	COc1c(Cl)c(F)ccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H22ClFN4O4/c1-31-22-16(3-2-14(25)19(22)24)29-21-18-15(5-8-27-23(18)30)28-20(21)13-4-7-26-10-17(13)33-11-12-6-9-32-12/h2-4,7,10,12,28-29H,5-6,8-9,11H2,1H3,(H,27,30)	UJVFITZVZXBDFT-UHFFFAOYSA-N	696431	3-(3-chloro-4-fluoro-2-methoxyanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 13	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696431	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696431&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445847	COc1c(Cl)c(F)ccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H22ClFN4O4/c1-31-22-16(3-2-14(25)19(22)24)29-21-18-15(5-8-27-23(18)30)28-20(21)13-4-7-26-10-17(13)33-11-12-6-9-32-12/h2-4,7,10,12,28-29H,5-6,8-9,11H2,1H3,(H,27,30)	UJVFITZVZXBDFT-UHFFFAOYSA-N	696432	(&#8722;)-3-(3-chloro-4-fluoro-2-methoxyanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 14	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 16300							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696432	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696432&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445848	COc1c(Cl)c(F)ccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H22ClFN4O4/c1-31-22-16(3-2-14(25)19(22)24)29-21-18-15(5-8-27-23(18)30)28-20(21)13-4-7-26-10-17(13)33-11-12-6-9-32-12/h2-4,7,10,12,28-29H,5-6,8-9,11H2,1H3,(H,27,30)	UJVFITZVZXBDFT-UHFFFAOYSA-N	696433	(+)-3-(3-chloro-4-fluoro-2-methoxyanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 15	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696433	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696433&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445849	Fc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2COC2)c1Cl	InChI=1S/C22H20ClFN4O3/c23-19-14(24)2-1-3-16(19)28-21-18-15(5-7-26-22(18)29)27-20(21)13-4-6-25-8-17(13)31-11-12-9-30-10-12/h1-4,6,8,12,27-28H,5,7,9-11H2,(H,26,29)	GYAMIWHHJCCHMA-UHFFFAOYSA-N	696434	3-(2-chloro-3-fluoroanilino)-2-{3-[(oxetan-3-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 16	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 13900							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696434	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696434&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445850	FC(F)Oc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1COC1	InChI=1S/C23H21ClF2N4O4/c24-14-2-1-3-16(21(14)34-23(25)26)30-20-18-15(5-7-28-22(18)31)29-19(20)13-4-6-27-8-17(13)33-11-12-9-32-10-12/h1-4,6,8,12,23,29-30H,5,7,9-11H2,(H,28,31)	GVKHRVZRXZDMHO-UHFFFAOYSA-N	696435	3-[3-chloro-2-(difluoromethoxy)anilino]-2-{3-[(oxetan-3-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 17	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 7520							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696435	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696435&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445851	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1COC1	InChI=1S/C23H23FN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-8-26-23(19)29)27-20(21)14-5-7-25-9-18(14)32-12-13-10-31-11-13/h2-5,7,9,13,27-28H,6,8,10-12H2,1H3,(H,26,29)	UUCWDVRQAYLICE-UHFFFAOYSA-N	696436	3-(3-fluoro-2-methoxyanilino)-2-{3-[(oxetan-3-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 18	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 12100							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696436	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696436&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445852	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25FN4O4/c1-24(8-11-33-24)13-32-18-12-26-9-6-14(18)20-21(19-16(28-20)7-10-27-23(19)30)29-17-5-3-4-15(25)22(17)31-2/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	DJTUCMZNDSOZGL-UHFFFAOYSA-N	696437	3-(3-fluoro-2-methoxyanilino)-2-{3-[(2-methyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 19	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 13700							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696437	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696437&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445853	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25FN4O4/c1-24(8-11-33-24)13-32-18-12-26-9-6-14(18)20-21(19-16(28-20)7-10-27-23(19)30)29-17-5-3-4-15(25)22(17)31-2/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	DJTUCMZNDSOZGL-UHFFFAOYSA-N	696438	(&#8722;)-3-(3-fluoro-2-methoxyanilino)-2-{3-[(2-methyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 20	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 11800							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696438	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696438&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445854	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25FN4O4/c1-24(8-11-33-24)13-32-18-12-26-9-6-14(18)20-21(19-16(28-20)7-10-27-23(19)30)29-17-5-3-4-15(25)22(17)31-2/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	DJTUCMZNDSOZGL-UHFFFAOYSA-N	696439	(+)-3-(3-fluoro-2-methoxyanilino)-2-{3-[(2-methyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 21	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696439	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696439&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445855	CCC1(COc2cnccc2-c2[nH]c3CCNC(=O)c3c2Nc2cccc(Cl)c2OC)COC1	InChI=1S/C25H27ClN4O4/c1-3-25(12-33-13-25)14-34-19-11-27-9-7-15(19)21-22(20-17(29-21)8-10-28-24(20)31)30-18-6-4-5-16(26)23(18)32-2/h4-7,9,11,29-30H,3,8,10,12-14H2,1-2H3,(H,28,31)	NUECLEPNQGICPE-UHFFFAOYSA-N	696440	3-(3-chloro-2-methoxyanilino)-2-{3-[(3-ethyloxetan-3-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 22	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 3830							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696440	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696440&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445856	CCC1(COc2cnccc2-c2[nH]c3CCNC(=O)c3c2Nc2cccc(Cl)c2C)COC1	InChI=1S/C25H27ClN4O3/c1-3-25(12-32-13-25)14-33-20-11-27-9-7-16(20)22-23(21-19(30-22)8-10-28-24(21)31)29-18-6-4-5-17(26)15(18)2/h4-7,9,11,29-30H,3,8,10,12-14H2,1-2H3,(H,28,31)	DQOVJQWXVRQTTM-UHFFFAOYSA-N	696441	3-(3-chloro-2-methylanilino)-2-{3-[(3-ethyloxetan-3-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 23	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>5710							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696441	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696441&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445857	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCCC1CCO1	InChI=1S/C24H25ClN4O4/c1-31-23-16(25)3-2-4-18(23)29-22-20-17(6-10-27-24(20)30)28-21(22)15-5-9-26-13-19(15)33-12-8-14-7-11-32-14/h2-5,9,13-14,28-29H,6-8,10-12H2,1H3,(H,27,30)	WRHXCULGAQMZFX-UHFFFAOYSA-N	696442	3-(3-chloro-2-methoxyanilino)-2-{3-[2-(oxetan-2-yl)ethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 24	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 2700							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696442	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696442&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445858	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCCC1CCO1	InChI=1S/C24H25ClN4O4/c1-31-23-16(25)3-2-4-18(23)29-22-20-17(6-10-27-24(20)30)28-21(22)15-5-9-26-13-19(15)33-12-8-14-7-11-32-14/h2-5,9,13-14,28-29H,6-8,10-12H2,1H3,(H,27,30)	WRHXCULGAQMZFX-UHFFFAOYSA-N	696443	(+)-3-(3-chloro-2-methoxyanilino)-2-{3-[2-(oxetan-2-yl)ethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 25	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 1080							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696443	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696443&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445859	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCCC1CCO1	InChI=1S/C24H25ClN4O4/c1-31-23-16(25)3-2-4-18(23)29-22-20-17(6-10-27-24(20)30)28-21(22)15-5-9-26-13-19(15)33-12-8-14-7-11-32-14/h2-5,9,13-14,28-29H,6-8,10-12H2,1H3,(H,27,30)	WRHXCULGAQMZFX-UHFFFAOYSA-N	696444	(&#8722;)-3-(3-chloro-2-methoxyanilino)-2-{3-[2-(oxetan-2-yl)ethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 26	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 1540							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696444	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696444&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445860	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@@H]1CCN1C |r|	InChI=1S/C24H26ClN5O3/c1-30-11-8-14(30)13-33-19-12-26-9-6-15(19)21-22(20-17(28-21)7-10-27-24(20)31)29-18-5-3-4-16(25)23(18)32-2/h3-6,9,12,14,28-29H,7-8,10-11,13H2,1-2H3,(H,27,31)	XAOLPFSIXBPUKD-UHFFFAOYSA-N	696445	3-(3-chloro-2-methoxyanilino)-2-(3-{[(2S)-1-methylazetidin-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 27	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 12300							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696445	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696445&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445861	CCN1CC[C@H]1COc1cnccc1-c1[nH]c2CCNC(=O)c2c1Nc1cccc(Cl)c1OC |r|	InChI=1S/C25H28ClN5O3/c1-3-31-12-9-15(31)14-34-20-13-27-10-7-16(20)22-23(21-18(29-22)8-11-28-25(21)32)30-19-6-4-5-17(26)24(19)33-2/h4-7,10,13,15,29-30H,3,8-9,11-12,14H2,1-2H3,(H,28,32)	VPLNFQDAWVGFIK-UHFFFAOYSA-N	696446	3-(3-chloro-2-methoxyanilino)-2-(3-{[(2S)-1-ethylazetidin-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 28	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696446	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696446&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445862	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@@H]1CCN1CC(F)(F)F |r|	InChI=1S/C25H25ClF3N5O3/c1-36-23-16(26)3-2-4-18(23)33-22-20-17(6-9-31-24(20)35)32-21(22)15-5-8-30-11-19(15)37-12-14-7-10-34(14)13-25(27,28)29/h2-5,8,11,14,32-33H,6-7,9-10,12-13H2,1H3,(H,31,35)	JGQDKIHXHXLKBY-UHFFFAOYSA-N	696447	3-(3-chloro-2-methoxyanilino)-2-(3-{[(2S)-1-(2,2,2-trifluoroethyl)azetidin-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 29	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696447	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696447&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445863	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@H]1CCN1CC(F)(F)F |r|	InChI=1S/C25H25ClF3N5O3/c1-36-23-16(26)3-2-4-18(23)33-22-20-17(6-9-31-24(20)35)32-21(22)15-5-8-30-11-19(15)37-12-14-7-10-34(14)13-25(27,28)29/h2-5,8,11,14,32-33H,6-7,9-10,12-13H2,1H3,(H,31,35)	JGQDKIHXHXLKBY-UHFFFAOYSA-N	696448	3-(3-chloro-2-methoxyanilino)-2-(3-{[(2R)-1-(2,2,2-trifluoroethyl)azetidin-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 30	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696448	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696448&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445864	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCN1C	InChI=1S/C25H28ClN5O3/c1-25(9-12-31(25)2)14-34-19-13-27-10-7-15(19)21-22(20-17(29-21)8-11-28-24(20)32)30-18-6-4-5-16(26)23(18)33-3/h4-7,10,13,29-30H,8-9,11-12,14H2,1-3H3,(H,28,32)	SKALBELAOWOPIC-UHFFFAOYSA-N	696449	3-(3-chloro-2-methoxyanilino)-2-{3-[(1,2-dimethylazetidin-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 31	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 7540							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696449	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696449&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445865	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCN1CC(F)(F)F	InChI=1S/C26H27ClF3N5O3/c1-25(8-11-35(25)13-26(28,29)30)14-38-19-12-31-9-6-15(19)21-22(20-17(33-21)7-10-32-24(20)36)34-18-5-3-4-16(27)23(18)37-2/h3-6,9,12,33-34H,7-8,10-11,13-14H2,1-2H3,(H,32,36)	AAWSCNSGDWBYRL-UHFFFAOYSA-N	696450	3-(3-chloro-2-methoxyanilino)-2-(3-{[2-methyl-1-(2,2,2-trifluoroethyl)azetidin-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 32	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696450	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696450&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445866	COc1c(Br)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H23BrN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-9-26-23(19)29)27-20(21)14-5-8-25-11-18(14)32-12-13-7-10-31-13/h2-5,8,11,13,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	HSEUQTHBEYTMEG-UHFFFAOYSA-N	696451	US20240307362, Example 33::3-(3-bromo-2-methoxyanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1, 5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 34::US20240307362, Example 35	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 8060							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696451	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696451&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445867	COc1c(Br)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H23BrN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-9-26-23(19)29)27-20(21)14-5-8-25-11-18(14)32-12-13-7-10-31-13/h2-5,8,11,13,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	HSEUQTHBEYTMEG-UHFFFAOYSA-N	696451	US20240307362, Example 33::3-(3-bromo-2-methoxyanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1, 5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 34::US20240307362, Example 35	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696451	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696451&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445868	COc1c(Br)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H23BrN4O4/c1-30-22-15(24)3-2-4-17(22)28-21-19-16(6-9-26-23(19)29)27-20(21)14-5-8-25-11-18(14)32-12-13-7-10-31-13/h2-5,8,11,13,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	HSEUQTHBEYTMEG-UHFFFAOYSA-N	696451	US20240307362, Example 33::3-(3-bromo-2-methoxyanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1, 5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 34::US20240307362, Example 35	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 4970							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696451	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696451&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445869	O=C1NCCc2[nH]c(c(Nc3cccc4CCCc34)c12)-c1ccncc1OCC1CCO1	InChI=1S/C25H26N4O3/c30-25-22-20(8-11-27-25)29-23(18-7-10-26-13-21(18)32-14-16-9-12-31-16)24(22)28-19-6-2-4-15-3-1-5-17(15)19/h2,4,6-7,10,13,16,28-29H,1,3,5,8-9,11-12,14H2,(H,27,30)	JRQXKSFDCJJOHX-UHFFFAOYSA-N	696454	3-[(2,3-dihydro-1H-inden-4-yl)amino]-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 36	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696454	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696454&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445870	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2CCO2)c1Cl	InChI=1S/C23H23ClN4O3/c1-13-3-2-4-17(20(13)24)28-22-19-16(6-9-26-23(19)29)27-21(22)15-5-8-25-11-18(15)31-12-14-7-10-30-14/h2-5,8,11,14,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	HXYQNURBSWYMIH-UHFFFAOYSA-N	696455	3-(2-chloro-3-methylanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 37	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 11700							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696455	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696455&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445871	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2CCO2)c1Cl	InChI=1S/C23H23ClN4O3/c1-13-3-2-4-17(20(13)24)28-22-19-16(6-9-26-23(19)29)27-21(22)15-5-8-25-11-18(15)31-12-14-7-10-30-14/h2-5,8,11,14,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	HXYQNURBSWYMIH-UHFFFAOYSA-N	696456	(+)-3-(2-chloro-3-methylanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 38	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696456	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696456&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445872	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2CCO2)c1Cl	InChI=1S/C23H23ClN4O3/c1-13-3-2-4-17(20(13)24)28-22-19-16(6-9-26-23(19)29)27-21(22)15-5-8-25-11-18(15)31-12-14-7-10-30-14/h2-5,8,11,14,27-28H,6-7,9-10,12H2,1H3,(H,26,29)	HXYQNURBSWYMIH-UHFFFAOYSA-N	696457	(&#8722;)-3-(2-chloro-3-methylanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 39	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 8320							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696457	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696457&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445873	Cc1c(Cl)cc(F)cc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H22ClFN4O3/c1-12-16(24)8-13(25)9-18(12)29-22-20-17(3-6-27-23(20)30)28-21(22)15-2-5-26-10-19(15)32-11-14-4-7-31-14/h2,5,8-10,14,28-29H,3-4,6-7,11H2,1H3,(H,27,30)	LZXZTUZMADCWEL-UHFFFAOYSA-N	696458	US20240307362, Example 40::US20240307362, Example 41::US20240307362, Example 42::3-(3-chloro-5-fluoro-2-methylanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 10500							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696458	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696458&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445874	Cc1c(Cl)cc(F)cc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H22ClFN4O3/c1-12-16(24)8-13(25)9-18(12)29-22-20-17(3-6-27-23(20)30)28-21(22)15-2-5-26-10-19(15)32-11-14-4-7-31-14/h2,5,8-10,14,28-29H,3-4,6-7,11H2,1H3,(H,27,30)	LZXZTUZMADCWEL-UHFFFAOYSA-N	696458	US20240307362, Example 40::US20240307362, Example 41::US20240307362, Example 42::3-(3-chloro-5-fluoro-2-methylanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 6350							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696458	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696458&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445875	Cc1c(Cl)cc(F)cc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H22ClFN4O3/c1-12-16(24)8-13(25)9-18(12)29-22-20-17(3-6-27-23(20)30)28-21(22)15-2-5-26-10-19(15)32-11-14-4-7-31-14/h2,5,8-10,14,28-29H,3-4,6-7,11H2,1H3,(H,27,30)	LZXZTUZMADCWEL-UHFFFAOYSA-N	696458	US20240307362, Example 40::US20240307362, Example 41::US20240307362, Example 42::3-(3-chloro-5-fluoro-2-methylanilino)-2-{3-[(oxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696458	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696458&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445876	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCCC1CCO1	InChI=1S/C24H25FN4O4/c1-31-23-16(25)3-2-4-18(23)29-22-20-17(6-10-27-24(20)30)28-21(22)15-5-9-26-13-19(15)33-12-8-14-7-11-32-14/h2-5,9,13-14,28-29H,6-8,10-12H2,1H3,(H,27,30)	ODAIREHMFFYMSF-UHFFFAOYSA-N	696461	US20240307362, Example 43::3-(3-fluoro-2-methoxyanilino)-2-{3-[2-(oxetan-2-yl)ethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 44::US20240307362, Example 45	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 3500							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696461	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696461&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445877	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCCC1CCO1	InChI=1S/C24H25FN4O4/c1-31-23-16(25)3-2-4-18(23)29-22-20-17(6-10-27-24(20)30)28-21(22)15-5-9-26-13-19(15)33-12-8-14-7-11-32-14/h2-5,9,13-14,28-29H,6-8,10-12H2,1H3,(H,27,30)	ODAIREHMFFYMSF-UHFFFAOYSA-N	696461	US20240307362, Example 43::3-(3-fluoro-2-methoxyanilino)-2-{3-[2-(oxetan-2-yl)ethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 44::US20240307362, Example 45	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696461	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696461&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445878	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCCC1CCO1	InChI=1S/C24H25FN4O4/c1-31-23-16(25)3-2-4-18(23)29-22-20-17(6-10-27-24(20)30)28-21(22)15-5-9-26-13-19(15)33-12-8-14-7-11-32-14/h2-5,9,13-14,28-29H,6-8,10-12H2,1H3,(H,27,30)	ODAIREHMFFYMSF-UHFFFAOYSA-N	696461	US20240307362, Example 43::3-(3-fluoro-2-methoxyanilino)-2-{3-[2-(oxetan-2-yl)ethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 44::US20240307362, Example 45	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 12700							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696461	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696461&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445879	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25ClN4O4/c1-24(8-11-33-24)13-32-18-12-26-9-6-14(18)20-21(19-16(28-20)7-10-27-23(19)30)29-17-5-3-4-15(25)22(17)31-2/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	WAYAVZXSRJPQKW-UHFFFAOYSA-N	696464	3-(3-chloro-2-methoxyanilino)-2-{3-[(2-methyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 46	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 10200							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696464	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696464&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445880	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25ClN4O4/c1-24(8-11-33-24)13-32-18-12-26-9-6-14(18)20-21(19-16(28-20)7-10-27-23(19)30)29-17-5-3-4-15(25)22(17)31-2/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	WAYAVZXSRJPQKW-UHFFFAOYSA-N	696465	(&#8722;)-3-(3-chloro-2-methoxyanilino)-2-{3-[(2-methyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 47	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 8860							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696465	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696465&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445881	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25ClN4O4/c1-24(8-11-33-24)13-32-18-12-26-9-6-14(18)20-21(19-16(28-20)7-10-27-23(19)30)29-17-5-3-4-15(25)22(17)31-2/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	WAYAVZXSRJPQKW-UHFFFAOYSA-N	696466	(+)-3-(3-chloro-2-methoxyanilino)-2-{3-[(2-methyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 48	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 10300							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696466	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696466&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445882	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1OCC1(C)C	InChI=1S/C25H27ClN4O4/c1-25(2)13-34-19(25)12-33-18-11-27-9-7-14(18)21-22(20-16(29-21)8-10-28-24(20)31)30-17-6-4-5-15(26)23(17)32-3/h4-7,9,11,19,29-30H,8,10,12-13H2,1-3H3,(H,28,31)	NNFFVTYHPCQYJN-UHFFFAOYSA-N	696467	3-(3-chloro-2-methoxyanilino)-2-{3-[(3,3-dimethyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 49	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696467	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696467&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445883	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1OCC1(C)C	InChI=1S/C25H27ClN4O4/c1-25(2)13-34-19(25)12-33-18-11-27-9-7-14(18)21-22(20-16(29-21)8-10-28-24(20)31)30-17-6-4-5-15(26)23(17)32-3/h4-7,9,11,19,29-30H,8,10,12-13H2,1-3H3,(H,28,31)	NNFFVTYHPCQYJN-UHFFFAOYSA-N	696468	(+)-3-(3-chloro-2-methoxyanilino)-2-{3-[(3,3-dimethyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 50	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696468	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696468&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445884	COc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1OCC1(C)C	InChI=1S/C25H27ClN4O4/c1-25(2)13-34-19(25)12-33-18-11-27-9-7-14(18)21-22(20-16(29-21)8-10-28-24(20)31)30-17-6-4-5-15(26)23(17)32-3/h4-7,9,11,19,29-30H,8,10,12-13H2,1-3H3,(H,28,31)	NNFFVTYHPCQYJN-UHFFFAOYSA-N	696469	(&#8722;)-3-(3-chloro-2-methoxyanilino)-2-{3-[(3,3-dimethyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 51	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 17100							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696469	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696469&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445885	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1OCC1(C)C	InChI=1S/C25H27FN4O4/c1-25(2)13-34-19(25)12-33-18-11-27-9-7-14(18)21-22(20-16(29-21)8-10-28-24(20)31)30-17-6-4-5-15(26)23(17)32-3/h4-7,9,11,19,29-30H,8,10,12-13H2,1-3H3,(H,28,31)	BJCRYONAAUDYKC-UHFFFAOYSA-N	696470	2-{3-[(3,3-dimethyloxetan-2-yl)methoxy]pyridin-4-yl}-3-(3-fluoro-2-methoxyanilino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 52	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696470	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696470&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445886	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1OCC1(C)C	InChI=1S/C25H27FN4O4/c1-25(2)13-34-19(25)12-33-18-11-27-9-7-14(18)21-22(20-16(29-21)8-10-28-24(20)31)30-17-6-4-5-15(26)23(17)32-3/h4-7,9,11,19,29-30H,8,10,12-13H2,1-3H3,(H,28,31)	BJCRYONAAUDYKC-UHFFFAOYSA-N	696471	(&#8722;)-2-{3-[(3,3-dimethyloxetan-2-yl)methoxy]pyridin-4-yl}-3-(3-fluoro-2-methoxyanilino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 53	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696471	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696471&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445887	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1OCC1(C)C	InChI=1S/C25H27FN4O4/c1-25(2)13-34-19(25)12-33-18-11-27-9-7-14(18)21-22(20-16(29-21)8-10-28-24(20)31)30-17-6-4-5-15(26)23(17)32-3/h4-7,9,11,19,29-30H,8,10,12-13H2,1-3H3,(H,28,31)	BJCRYONAAUDYKC-UHFFFAOYSA-N	696472	(+)-2-{3-[(3,3-dimethyloxetan-2-yl)methoxy]pyridin-4-yl}-3-(3-fluoro-2-methoxyanilino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 54	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696472	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696472&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445888	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2(C)CCO2)c1Cl	InChI=1S/C24H25ClN4O3/c1-14-4-3-5-17(20(14)25)29-22-19-16(7-10-27-23(19)30)28-21(22)15-6-9-26-12-18(15)31-13-24(2)8-11-32-24/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	RBTLEYBFYMGLPY-UHFFFAOYSA-N	696473	3-(2-chloro-3-methylanilino)-2-{3-[(2-methyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 55	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 15400							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696473	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696473&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445889	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2(C)CCO2)c1Cl	InChI=1S/C24H25ClN4O3/c1-14-4-3-5-17(20(14)25)29-22-19-16(7-10-27-23(19)30)28-21(22)15-6-9-26-12-18(15)31-13-24(2)8-11-32-24/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	RBTLEYBFYMGLPY-UHFFFAOYSA-N	696474	(+)-3-(2-chloro-3-methylanilino)-2-{3-[(2-methyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 56	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 16100							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696474	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696474&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445890	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2(C)CCO2)c1Cl	InChI=1S/C24H25ClN4O3/c1-14-4-3-5-17(20(14)25)29-22-19-16(7-10-27-23(19)30)28-21(22)15-6-9-26-12-18(15)31-13-24(2)8-11-32-24/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	RBTLEYBFYMGLPY-UHFFFAOYSA-N	696475	(&#8722;)-3-(2-chloro-3-methylanilino)-2-{3-[(2-methyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 57	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 13000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696475	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696475&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445891	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2OCC2(C)C)c1Cl	InChI=1S/C25H27ClN4O3/c1-14-5-4-6-17(21(14)26)30-23-20-16(8-10-28-24(20)31)29-22(23)15-7-9-27-11-18(15)32-12-19-25(2,3)13-33-19/h4-7,9,11,19,29-30H,8,10,12-13H2,1-3H3,(H,28,31)	IWYZJYOKHWHOBO-UHFFFAOYSA-N	696476	3-(2-chloro-3-methylanilino)-2-{3-[(3,3-dimethyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 58	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696476	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696476&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445892	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2OCC2(C)C)c1Cl	InChI=1S/C25H27ClN4O3/c1-14-5-4-6-17(21(14)26)30-23-20-16(8-10-28-24(20)31)29-22(23)15-7-9-27-11-18(15)32-12-19-25(2,3)13-33-19/h4-7,9,11,19,29-30H,8,10,12-13H2,1-3H3,(H,28,31)	IWYZJYOKHWHOBO-UHFFFAOYSA-N	696477	(+)-3-(2-chloro-3-methylanilino)-2-{3-[(3,3-dimethyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 59	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696477	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696477&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445893	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2OCC2(C)C)c1Cl	InChI=1S/C25H27ClN4O3/c1-14-5-4-6-17(21(14)26)30-23-20-16(8-10-28-24(20)31)29-22(23)15-7-9-27-11-18(15)32-12-19-25(2,3)13-33-19/h4-7,9,11,19,29-30H,8,10,12-13H2,1-3H3,(H,28,31)	IWYZJYOKHWHOBO-UHFFFAOYSA-N	696478	(&#8722;)-3-(2-chloro-3-methylanilino)-2-{3-[(3,3-dimethyloxetan-2-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 60	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 18800							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696478	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696478&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445894	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(F)COC1	InChI=1S/C23H22F2N4O4/c1-31-21-14(24)3-2-4-16(21)29-20-18-15(6-8-27-22(18)30)28-19(20)13-5-7-26-9-17(13)33-12-23(25)10-32-11-23/h2-5,7,9,28-29H,6,8,10-12H2,1H3,(H,27,30)	JBEIWZWWBOIWRA-UHFFFAOYSA-N	696479	3-(3-fluoro-2-methoxyanilino)-2-{3-[(3-fluorooxetan-3-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 61	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696479	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696479&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445895	Cc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCCC2CCO2)c1Cl	InChI=1S/C24H25ClN4O3/c1-14-3-2-4-18(21(14)25)29-23-20-17(6-10-27-24(20)30)28-22(23)16-5-9-26-13-19(16)32-12-8-15-7-11-31-15/h2-5,9,13,15,28-29H,6-8,10-12H2,1H3,(H,27,30)	QZQGIDLXPFWWKW-UHFFFAOYSA-N	696480	3-(2-chloro-3-methylanilino)-2-{3-[2-(oxetan-2-yl)ethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 62	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 5250							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696480	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696480&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445896	Clc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCCC2CCO2)c1Cl	InChI=1S/C23H22Cl2N4O3/c24-15-2-1-3-17(20(15)25)29-22-19-16(5-9-27-23(19)30)28-21(22)14-4-8-26-12-18(14)32-11-7-13-6-10-31-13/h1-4,8,12-13,28-29H,5-7,9-11H2,(H,27,30)	PBJQSVYLISRMDO-UHFFFAOYSA-N	696481	US20240307362, Example 63::3-(2,3-dichloroanilino)-2-(3-{2-[oxetan-2-yl]ethoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 64	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 5510							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696481	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696481&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445897	Clc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCCC2CCO2)c1Cl	InChI=1S/C23H22Cl2N4O3/c24-15-2-1-3-17(20(15)25)29-22-19-16(5-9-27-23(19)30)28-21(22)14-4-8-26-12-18(14)32-11-7-13-6-10-31-13/h1-4,8,12-13,28-29H,5-7,9-11H2,(H,27,30)	PBJQSVYLISRMDO-UHFFFAOYSA-N	696481	US20240307362, Example 63::3-(2,3-dichloroanilino)-2-(3-{2-[oxetan-2-yl]ethoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 64	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 5380							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696481	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696481&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445898	COc1c(Cl)cc(F)cc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H22ClFN4O4/c1-31-22-15(24)8-12(25)9-17(22)29-21-19-16(3-6-27-23(19)30)28-20(21)14-2-5-26-10-18(14)33-11-13-4-7-32-13/h2,5,8-10,13,28-29H,3-4,6-7,11H2,1H3,(H,27,30)	FLRRWFWNBSISCE-UHFFFAOYSA-N	696483	US20240307362, Example 65::3-(3-chloro-5-fluoro-2-methoxyanilino)-2-(3-{[oxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 66::US20240307362, Example 67	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696483	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696483&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445899	COc1c(Cl)cc(F)cc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H22ClFN4O4/c1-31-22-15(24)8-12(25)9-17(22)29-21-19-16(3-6-27-23(19)30)28-20(21)14-2-5-26-10-18(14)33-11-13-4-7-32-13/h2,5,8-10,13,28-29H,3-4,6-7,11H2,1H3,(H,27,30)	FLRRWFWNBSISCE-UHFFFAOYSA-N	696483	US20240307362, Example 65::3-(3-chloro-5-fluoro-2-methoxyanilino)-2-(3-{[oxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 66::US20240307362, Example 67	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696483	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696483&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445900	COc1c(Cl)cc(F)cc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C23H22ClFN4O4/c1-31-22-15(24)8-12(25)9-17(22)29-21-19-16(3-6-27-23(19)30)28-20(21)14-2-5-26-10-18(14)33-11-13-4-7-32-13/h2,5,8-10,13,28-29H,3-4,6-7,11H2,1H3,(H,27,30)	FLRRWFWNBSISCE-UHFFFAOYSA-N	696483	US20240307362, Example 65::3-(3-chloro-5-fluoro-2-methoxyanilino)-2-(3-{[oxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 66::US20240307362, Example 67	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696483	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696483&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445901	COc1c(Cl)cc(F)cc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H24ClFN4O4/c1-24(5-8-34-24)12-33-18-11-27-6-3-14(18)20-21(19-16(29-20)4-7-28-23(19)31)30-17-10-13(26)9-15(25)22(17)32-2/h3,6,9-11,29-30H,4-5,7-8,12H2,1-2H3,(H,28,31)	VELMTONNZHUPQP-UHFFFAOYSA-N	696486	US20240307362, Example 68::US20240307362, Example 70::3-(3-chloro-5-fluoro-2-methoxyanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 69	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696486	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696486&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445902	COc1c(Cl)cc(F)cc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H24ClFN4O4/c1-24(5-8-34-24)12-33-18-11-27-6-3-14(18)20-21(19-16(29-20)4-7-28-23(19)31)30-17-10-13(26)9-15(25)22(17)32-2/h3,6,9-11,29-30H,4-5,7-8,12H2,1-2H3,(H,28,31)	VELMTONNZHUPQP-UHFFFAOYSA-N	696486	US20240307362, Example 68::US20240307362, Example 70::3-(3-chloro-5-fluoro-2-methoxyanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 69	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 13500							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696486	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696486&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445903	COc1c(Cl)cc(F)cc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H24ClFN4O4/c1-24(5-8-34-24)12-33-18-11-27-6-3-14(18)20-21(19-16(29-20)4-7-28-23(19)31)30-17-10-13(26)9-15(25)22(17)32-2/h3,6,9-11,29-30H,4-5,7-8,12H2,1-2H3,(H,28,31)	VELMTONNZHUPQP-UHFFFAOYSA-N	696486	US20240307362, Example 68::US20240307362, Example 70::3-(3-chloro-5-fluoro-2-methoxyanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 69	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 18800							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696486	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696486&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445904	CC1(C)COC1COc1cnccc1-c1[nH]c2CCNC(=O)c2c1Nc1cccc(Cl)c1OC(F)F	InChI=1S/C25H25ClF2N4O4/c1-25(2)12-35-18(25)11-34-17-10-29-8-6-13(17)20-21(19-15(31-20)7-9-30-23(19)33)32-16-5-3-4-14(26)22(16)36-24(27)28/h3-6,8,10,18,24,31-32H,7,9,11-12H2,1-2H3,(H,30,33)	RTFDMXFTQZCKAO-UHFFFAOYSA-N	696489	US20240307362, Example 71::US20240307362, Example 72::US20240307362, Example 73::3-[3-chloro-2-(difluoromethoxy)anilino]-2-(3-{[3,3-dimethyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696489	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696489&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445905	CC1(C)COC1COc1cnccc1-c1[nH]c2CCNC(=O)c2c1Nc1cccc(Cl)c1OC(F)F	InChI=1S/C25H25ClF2N4O4/c1-25(2)12-35-18(25)11-34-17-10-29-8-6-13(17)20-21(19-15(31-20)7-9-30-23(19)33)32-16-5-3-4-14(26)22(16)36-24(27)28/h3-6,8,10,18,24,31-32H,7,9,11-12H2,1-2H3,(H,30,33)	RTFDMXFTQZCKAO-UHFFFAOYSA-N	696489	US20240307362, Example 71::US20240307362, Example 72::US20240307362, Example 73::3-[3-chloro-2-(difluoromethoxy)anilino]-2-(3-{[3,3-dimethyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696489	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696489&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445906	CC1(C)COC1COc1cnccc1-c1[nH]c2CCNC(=O)c2c1Nc1cccc(Cl)c1OC(F)F	InChI=1S/C25H25ClF2N4O4/c1-25(2)12-35-18(25)11-34-17-10-29-8-6-13(17)20-21(19-15(31-20)7-9-30-23(19)33)32-16-5-3-4-14(26)22(16)36-24(27)28/h3-6,8,10,18,24,31-32H,7,9,11-12H2,1-2H3,(H,30,33)	RTFDMXFTQZCKAO-UHFFFAOYSA-N	696489	US20240307362, Example 71::US20240307362, Example 72::US20240307362, Example 73::3-[3-chloro-2-(difluoromethoxy)anilino]-2-(3-{[3,3-dimethyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696489	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696489&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445907	CC1(COc2cnccc2-c2[nH]c3CCNC(=O)c3c2Nc2cccc(Cl)c2OC(F)F)CCO1	InChI=1S/C24H23ClF2N4O4/c1-24(7-10-34-24)12-33-17-11-28-8-5-13(17)19-20(18-15(30-19)6-9-29-22(18)32)31-16-4-2-3-14(25)21(16)35-23(26)27/h2-5,8,11,23,30-31H,6-7,9-10,12H2,1H3,(H,29,32)	DBSFBNGNNCTWKI-UHFFFAOYSA-N	696492	US20240307362, Example 74::US20240307362, Example 75::3-[3-chloro-2-(difluoromethoxy)anilino]-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 76	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696492	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696492&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445908	CC1(COc2cnccc2-c2[nH]c3CCNC(=O)c3c2Nc2cccc(Cl)c2OC(F)F)CCO1	InChI=1S/C24H23ClF2N4O4/c1-24(7-10-34-24)12-33-17-11-28-8-5-13(17)19-20(18-15(30-19)6-9-29-22(18)32)31-16-4-2-3-14(25)21(16)35-23(26)27/h2-5,8,11,23,30-31H,6-7,9-10,12H2,1H3,(H,29,32)	DBSFBNGNNCTWKI-UHFFFAOYSA-N	696492	US20240307362, Example 74::US20240307362, Example 75::3-[3-chloro-2-(difluoromethoxy)anilino]-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 76	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696492	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696492&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445909	CC1(COc2cnccc2-c2[nH]c3CCNC(=O)c3c2Nc2cccc(Cl)c2OC(F)F)CCO1	InChI=1S/C24H23ClF2N4O4/c1-24(7-10-34-24)12-33-17-11-28-8-5-13(17)19-20(18-15(30-19)6-9-29-22(18)32)31-16-4-2-3-14(25)21(16)35-23(26)27/h2-5,8,11,23,30-31H,6-7,9-10,12H2,1H3,(H,29,32)	DBSFBNGNNCTWKI-UHFFFAOYSA-N	696492	US20240307362, Example 74::US20240307362, Example 75::3-[3-chloro-2-(difluoromethoxy)anilino]-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 76	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696492	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696492&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445910	CCc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1CCO1	InChI=1S/C24H25ClN4O3/c1-2-15-17(25)4-3-5-18(15)28-23-21-19(7-10-27-24(21)30)29-22(23)16-6-9-26-12-20(16)32-13-14-8-11-31-14/h3-6,9,12,14,28-29H,2,7-8,10-11,13H2,1H3,(H,27,30)	MLABNBQNHFFTEX-UHFFFAOYSA-N	696495	3-(3-chloro-2-ethylanilino)-2-(3-{[oxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 77	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 1760							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696495	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696495&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445911	CCc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C25H27ClN4O3/c1-3-15-17(26)5-4-6-18(15)29-23-21-19(8-11-28-24(21)31)30-22(23)16-7-10-27-13-20(16)32-14-25(2)9-12-33-25/h4-7,10,13,29-30H,3,8-9,11-12,14H2,1-2H3,(H,28,31)	FRDBERWGGHAWIN-UHFFFAOYSA-N	696496	3-(3-chloro-2-ethylanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 78	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 2800							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696496	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696496&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445912	COc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@H]1CCN1C |r|	InChI=1S/C24H26FN5O3/c1-30-11-8-14(30)13-33-19-12-26-9-6-15(19)21-22(20-17(28-21)7-10-27-24(20)31)29-18-5-3-4-16(25)23(18)32-2/h3-6,9,12,14,28-29H,7-8,10-11,13H2,1-2H3,(H,27,31)	QVGPGCWVZNRVHU-UHFFFAOYSA-N	696497	3-(3-fluoro-2-methoxyanilino)-2-(3-{[(2R)-1-methylazetidin-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 79	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696497	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696497&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445913	Cc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25ClN4O3/c1-14-16(25)4-3-5-17(14)28-22-20-18(7-10-27-23(20)30)29-21(22)15-6-9-26-12-19(15)31-13-24(2)8-11-32-24/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	HAZKVKWVLOVCKD-UHFFFAOYSA-N	696498	US20240307362, Example 80::3-(3-chloro-2-methylanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 81	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 6640							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696498	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696498&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445914	Cc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25ClN4O3/c1-14-16(25)4-3-5-17(14)28-22-20-18(7-10-27-23(20)30)29-21(22)15-6-9-26-12-19(15)31-13-24(2)8-11-32-24/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	HAZKVKWVLOVCKD-UHFFFAOYSA-N	696498	US20240307362, Example 80::3-(3-chloro-2-methylanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 81	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 5050							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696498	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696498&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445915	Cc1c(Cl)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OC[C@]1(C)CCO1 |r|	InChI=1S/C24H25ClN4O3/c1-14-16(25)4-3-5-17(14)28-22-20-18(7-10-27-23(20)30)29-21(22)15-6-9-26-12-19(15)31-13-24(2)8-11-32-24/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	HAZKVKWVLOVCKD-UHFFFAOYSA-N	696500	(+)-3-(3-chloro-2-methylanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 82	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 5980							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696500	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696500&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445916	Cc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25FN4O3/c1-14-16(25)4-3-5-17(14)28-22-20-18(7-10-27-23(20)30)29-21(22)15-6-9-26-12-19(15)31-13-24(2)8-11-32-24/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	QVHMIYFARBLZEB-UHFFFAOYSA-N	696501	3-(3-fluoro-2-methylanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 83	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>20000							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696501	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696501&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445917	Cc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25FN4O3/c1-14-16(25)4-3-5-17(14)28-22-20-18(7-10-27-23(20)30)29-21(22)15-6-9-26-12-19(15)31-13-24(2)8-11-32-24/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	QVHMIYFARBLZEB-UHFFFAOYSA-N	696502	(&#8722;)-3-(3-fluoro-2-methylanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 84	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 14900							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696502	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696502&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445918	Cc1c(F)cccc1Nc1c([nH]c2CCNC(=O)c12)-c1ccncc1OCC1(C)CCO1	InChI=1S/C24H25FN4O3/c1-14-16(25)4-3-5-17(14)28-22-20-18(7-10-27-23(20)30)29-21(22)15-6-9-26-12-19(15)31-13-24(2)8-11-32-24/h3-6,9,12,28-29H,7-8,10-11,13H2,1-2H3,(H,27,30)	QVHMIYFARBLZEB-UHFFFAOYSA-N	696503	(+)-3-(3-fluoro-2-methylanilino)-2-(3-{[2-methyloxetan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 85	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 15800							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696503	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696503&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445919	CCC1(COc2cnccc2-c2[nH]c3CCNC(=O)c3c2Nc2cccc(C)c2Cl)COC1	InChI=1S/C25H27ClN4O3/c1-3-25(12-32-13-25)14-33-19-11-27-9-7-16(19)22-23(20-17(29-22)8-10-28-24(20)31)30-18-6-4-5-15(2)21(18)26/h4-7,9,11,29-30H,3,8,10,12-14H2,1-2H3,(H,28,31)	DHNUUPBVRMMLTO-UHFFFAOYSA-N	696504	3-(2-chloro-3-methylanilino)-2-{3-[(3-ethyloxetan-3-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 86	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>5700							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696504	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696504&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445920	CCC1(COc2cnccc2-c2[nH]c3CCNC(=O)c3c2Nc2cccc(Cl)c2Cl)COC1	InChI=1S/C24H24Cl2N4O3/c1-2-24(11-32-12-24)13-33-18-10-27-8-6-14(18)21-22(19-16(29-21)7-9-28-23(19)31)30-17-5-3-4-15(25)20(17)26/h3-6,8,10,29-30H,2,7,9,11-13H2,1H3,(H,28,31)	SLTMZQMCXDPIIT-UHFFFAOYSA-N	696505	3-(2,3-dichloroanilino)-2-{3-[(3-ethyloxetan-3-yl)methoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 87	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		>5700							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696505	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696505&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1445921	CCC1(COc2cnccc2-c2[nH]c3CCNC(=O)c3c2Nc2cccc(F)c2OC)COC1	InChI=1S/C25H27FN4O4/c1-3-25(12-33-13-25)14-34-19-11-27-9-7-15(19)21-22(20-17(29-21)8-10-28-24(20)31)30-18-6-4-5-16(26)23(18)32-2/h4-7,9,11,29-30H,3,8,10,12-14H2,1-2H3,(H,28,31)	BCOBOKVIVYIAHU-UHFFFAOYSA-N	696506	2-{3-[(3-ethyloxetan-3-yl)methoxy]pyridin-4-yl}-3-(3-fluoro-2-methoxyanilino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US20240307362, Example 88	Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085]	Homo sapiens		 7490							US Patent		10.7270/Q2P273NX		aid2060393	US20240307362	SIEGEL, S; SIEGEL, F; SCHULZE, V; BERGER, M; GRAHAM, K; GRADL, SN; S&#220;LZLE, D; BOMER, U; KORR, D; SCHRODER, J; MONNING, U; NIEHUES, M; MEYERSON, M; GREULICH, H; KAPLAN, B; HARB, HY; DINH, PM	9/19/2024	1/16/2025	Bayer Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=696506	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=696506&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search											1	DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK	4R8Q,6F7B	Mitotic checkpoint serine/threonine-protein kinase BUB1	BUB1_HUMAN	O43683	E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4